224 related articles for article (PubMed ID: 26542589)
1. Tumor Characteristics and Survival Outcome of Endometrial Cancer Arising in Adenomyosis: An Exploratory Analysis.
Matsuo K; Moeini A; Machida H; Scannell CA; Casabar JK; Kakuda M; Adachi S; Garcia-Sayre J; Ueda Y; Roman LD
Ann Surg Oncol; 2016 Mar; 23(3):959-67. PubMed ID: 26542589
[TBL] [Abstract][Full Text] [Related]
2. Endometrial cancer arising in adenomyosis versus endometrial cancer coexisting with adenomyosis: are these two different entities?
Machida H; Maeda M; Cahoon SS; Scannell CA; Garcia-Sayre J; Roman LD; Matsuo K
Arch Gynecol Obstet; 2017 Jun; 295(6):1459-1468. PubMed ID: 28444512
[TBL] [Abstract][Full Text] [Related]
3. Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer.
Matsuo K; Cahoon SS; Gualtieri M; Scannell CA; Jung CE; Takano T; Paulson RJ; Muderspach LI; Roman LD
Ann Surg Oncol; 2014 Dec; 21(13):4246-55. PubMed ID: 25001096
[TBL] [Abstract][Full Text] [Related]
4. The clinicopathological characteristics and survival outcomes of endometrial carcinoma coexisting with or arising in adenomyosis: A pilot study.
Chao X; Wu M; Ma S; Tan X; Zhong S; Bi Y; Wu H; Lang J; Li L
Sci Rep; 2020 Apr; 10(1):5984. PubMed ID: 32249826
[TBL] [Abstract][Full Text] [Related]
5. Whether surgical procedure can improve the prognosis of endometrial cancer arising in adenomyosis (EC-AIA)? A systematic review and meta-analysis.
Sun Y; Lin S; Wu W; Nie F; Liu Y; Wen J; Cheng X; Liu Q; Wang Y; Ren F
Int J Surg; 2024 May; 110(5):3072-3080. PubMed ID: 38445439
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Adenomyosis in Myometrial Invasion and Overall Survival in Endometrial Cancer.
Erkilinç S; Taylan E; Gülseren V; Erkilinç G; Karadeniz T; Bağci M; Temel O; Solmaz U; Gökçü M; Sanci M
Int J Gynecol Cancer; 2018 Jan; 28(1):145-151. PubMed ID: 29040186
[TBL] [Abstract][Full Text] [Related]
7. Coexistence of uterine adenomyosis is not associated with a better prognosis in endometrioid-type endometrial cancer.
Aslan K; Sarı ME; Yalçın HR; Yalçın İ; Cüylan ZF; Özdal B
Ir J Med Sci; 2020 Aug; 189(3):835-842. PubMed ID: 31970616
[TBL] [Abstract][Full Text] [Related]
8. Impact of Coexisting Uterine Adenomyosis on the Survival Outcome of Patients with Endometrial Cancer: A Retrospective Cohort Study.
Boonlak S; Aue-Aungkul A; Kietpeerakool C; Kleebkaow P; Chumworathayi B; Luanratanakorn S; Temtanakitpaisan A
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1185-1190. PubMed ID: 31030493
[TBL] [Abstract][Full Text] [Related]
9. The Risks for Ovarian, Endometrial, Breast, Colorectal, and Other Cancers in Women With Newly Diagnosed Endometriosis or Adenomyosis: A Population-Based Study.
Kok VC; Tsai HJ; Su CF; Lee CK
Int J Gynecol Cancer; 2015 Jul; 25(6):968-76. PubMed ID: 25893280
[TBL] [Abstract][Full Text] [Related]
10. Influences of uterine adenomyosis on muscle invasion and prognosis of endometrioid adenocarcinoma.
Taneichi A; Fujiwara H; Takahashi Y; Takei Y; Machida S; Saga Y; Takahashi S; Suzuki M
Int J Gynecol Cancer; 2014 Oct; 24(8):1429-33. PubMed ID: 25188882
[TBL] [Abstract][Full Text] [Related]
11. Adenomyosis and Endometrial Cancer: Literature Review.
Habiba M; Pluchino N; Petignat P; Bianchi P; Brosens IA; Benagiano G
Gynecol Obstet Invest; 2018; 83(4):313-328. PubMed ID: 29874641
[TBL] [Abstract][Full Text] [Related]
12. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
13. Diffusely infiltrative endometrial adenocarcinoma: an adenoma malignum pattern of myoinvasion.
Longacre TA; Hendrickson MR
Am J Surg Pathol; 1999 Jan; 23(1):69-78. PubMed ID: 9888705
[TBL] [Abstract][Full Text] [Related]
14. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.
Ismiil ND; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Thomas G; Ackerman I; Covens A; Khalifa MA
Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412
[TBL] [Abstract][Full Text] [Related]
15. Impact of coexistent adenomyosis on outcomes of patients with endometrioid endometrial cancer: a propensity score-matched analysis.
Aydin HA; Toptas T; Bozkurt S; Pestereli E; Simsek T
Tumori; 2018; 104(1):60-65. PubMed ID: 29192745
[TBL] [Abstract][Full Text] [Related]
16. Microvessel density (MVD) as a prognosticator in endometrial carcinoma.
Ozalp S; Yalcin OT; Acikalin M; Tanir HM; Oner U; Akkoyunlu A
Eur J Gynaecol Oncol; 2003; 24(3-4):305-8. PubMed ID: 12807245
[TBL] [Abstract][Full Text] [Related]
17. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of co-existent adenomyosis on outcomes and tumor characteristics of endometrial cancer: A meta-analysis.
An M; Duan H; Zhang Y
J Obstet Gynaecol Res; 2020 Sep; 46(9):1851-1863. PubMed ID: 32686169
[TBL] [Abstract][Full Text] [Related]
19. An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma.
Liang LW; Perez AR; Cangemi NA; Zhou Q; Iasonos A; Abu-Rustum N; Alektiar KM; Makker V
Int J Gynecol Cancer; 2016 Mar; 26(3):497-504. PubMed ID: 26825840
[TBL] [Abstract][Full Text] [Related]
20. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]